Skip to main content

UK's first project for medical cannabis launches - EPM Magazine

UK's first project for medical cannabis launches - EPM Magazine


The UK’s first national medical cannabis project has been launched with a goal of recruiting 20,000 patients before the end of 2021.



Launched by Drug Science’s Medical Cannabis Working Group, Project TWENTY21 will focus on a range of patients and situations where alternative treatments have failed. These include patients with chronic pain, PTSD with a focus on the veteran community, multiple sclerosis and Tourette’s. More so the project will place a particular focus on prison populations who are susceptible to harm and substance use disorder as a harm reduction strategy.


The project will develop a body of evidence using a real-world data registry which documents the efficacy, safety, QALY (quality, adjusted, life, year) and patient reported outcomes in those prescribed medical cannabis.


The data will be used to assist health authorities to assess patient applications in the hope that there will soon be a new regulatory system for medical cannabis in the UK.


Drug Science chair professor David Nutt said: “Cannabis was a medicine in the UK for over a century until 1971 when it was banned for political reasons. Since then hundreds of thousands of patients have been forced to break the law to get a treatment that most find preferable to their previous prescription medicines. Despite the UK making cannabis a medicine in November 2018 there have as yet been only a handful of prescriptions on the NHS. To rectify this impasse Drug Science has joined forces with the United Patients Alliance, leading academics and several medical cannabis producers to open up a treatment network for up to 20,000 patients. This will allow patients to get vital therapy without breaking the law. It will also provide a solid clinical database from which experience of and confidence in, medical cannabis prescribing will develop, providing a foundation for other medical prescribers to build on.”


Australian medical cannabis group Althea has been selected to supply its range of products to the project.


Althea chief medical officer Dr Robert Pawinski said: “Althea is proud to be able to provide the product as part of the national pilot, and resources to ensure patient access. We believe the pilot program will yield valuable data that can then be used to further bolster the case for medical cannabis use and inform public health and stakeholder decisions.”









Let's block ads! (Why?)



https://www.epmmagazine.com/news/uk-s-fi...-launches/

from potads - All Forums learn more

Popular posts from this blog

Martha Stewart launches CBD line in crowded market - CNN

Martha Stewart launches CBD line in crowded market - CNN The hemp-derived, cannabidiol-rich gummies, soft gels and oil drops officially launched on Thursday after more than a year in development. The products are the result of the style maven's partnership with Canopy Growth ( CGC ) , the Canadian cannabis company with a multibillion-dollar backer in US alcohol giant Constellation Brands ( STZ ) . Stewart joined Canopy as an adviser in early 2019 for the express purpose of developing cannabis products for humans and their pets after being introduced to Canopy's founder by her friend Calvin Broadus Jr. -- the rapper and businessman better known as Snoop Dogg. His Leafs by Snoop cannabis brand is produced by Canopy. The initial Martha Stewart CBD products, which range from $34.99 to $44.99, will be sold online at Canopy's e-commerce site . The pet products are expected to debut later this year. "I was surprised to learn that while most people have heard of ...
Read more

The Half-Legal Cannabis Trap - POLITICO

The Half-Legal Cannabis Trap - POLITICO LOS ANGELES — Everything about Kelvin’s job in a neighborhood southwest of downtown seemed like any other assignment, if not a little more exciting. The 40-year-old, who had previously worked as an electrician, had been employed since 2015 by a private security company that contracted him out to guard marijuana dispensaries. In 2019, he was protecting one of the thousand or so cannabis stores in California’s biggest city—part of an industry that has grown less and less underground since 1996, when the state first legalized medical marijuana. Kelvin, who asked not to be identified beyond his middle name to avoid professional retaliation, doesn’t smoke pot, but says the gig felt like the future. He grew up in a time when other Black people he knew in Los Angeles would go to jail for possessing even small amounts of the drug. Now, customers could walk into shops like the one he was guarding, many of which can be identified by green crosses on...
Read more

Cannabis news worldwide -- Some Indian farmers are turning moon-gazers

Some Indian farmers are turning moon-gazers A growing number of cultivators opt for biodynamic techniques to give farming a zodiac twist Sarvdaman Patel , 69, stands between rows of legumes and parsley at high noon, but it is not the harsh sun that bothers him. He is obsessed with the moon. "It is currently in the Air sign which is ideal for flowering plants," he remarks, peering at the marigolds. Patel is no Bejan Daruwala. He is an Indian farmer who has been using biodynamic (BD) techniques for the last 16 years on his farm in Gujarat's Anand. The BD cultivation calendar is based on the moon's movement through each zodiac every two-and-a-half days covering all 12 signs every month. An unofficial estimate by the Biodynamic Association of India (BDAI) says about one lakh farmers in Maharashtra, Andhra Pradesh, Punjab and Uttarakhand practise biodynamic farming. However, most of the produce is sold under the generic 'organic' label as few consumers unde...
Read more